Deep learning radiomics model for lymph node metastases prediction: a diagnostic study
Related Experiment Video
Updated: Nov 9, 2026
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
Yongbin Li1,2, Shangdi Wu1,3, Jiajun Qiu4
1Division of Pancreatic Surgery, Department of General Surgery, West China Hospital of Sichuan University, Chengdu, China.
Background:
Pancreatic ductal adenocarcinoma (PDAC) frequently exhibits lymph node (LN) metastasis, making early identification of high-risk patients crucial for optimizing treatment strategies. However, robust predictive models and external validation remain limited. This study aimed to develop and validate an artificial intelligence (AI) model for preoperative detection of LN status in PDAC patients.
Methods:
We retrospectively enrolled 233 pathologically confirmed PDAC patients from two high-volume pancreatic surgery centers between July 2015 and July 2022. All patients underwent contrast-enhanced computed tomography (CT) scans and met strict inclusion and exclusion criteria. Two experienced radiologists independently reviewed imaging. Radiomics analysis was performed using MATLAB and Python-based PyRadiomics. Following feature selection, 14 radiomic features were retained to construct a radiomics score. Three predictive models were developed and compared.
Results:
From 1,652 extracted radiomic features, 14 were selected to build a radiomics score significantly associated with LN metastasis (P<0.001). Multivariate logistic regression identified tumor location, vascular invasion, white blood cell (WBC) count, platelet count, and radiomics score as independent predictors of LN metastasis, and a nomogram was generated. Various machine learning algorithms were evaluated to identify the optimal model combining radiomic and clinical data. Decision curve analysis demonstrated that the extreme gradient boosting (XGBoost) model achieved superior accuracy and stability, with an area under the curve (AUC) of 0.86 in the training set and 0.81 in the validation set.
Conclusions:
We successfully developed a LN metastasis prediction model integrating preoperative CT radiomics and clinical variables. The XGBoost-based model exhibited excellent accuracy, robustness, and generalizability. Future studies should focus on constructing more reliable models through standardized pathological sampling and prospective multicenter trials, alongside advancing imaging techniques to improve identification of small LNs.